MAULI PATEL: Open Payments
NPI 1578087235 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 18 payments from 6 companies in 2025. Trend: 2023 $624 · 2024 $213 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $204 |
| PFIZER INC. | 5 | $91 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: CARDIOMEMS, VYNDAQEL, LEQVIO, VERQUVO, WAINUA, CAPVAXIVE, Kerendia.
Industry payments across NY — which companies pay providers there.
